Abstract Boron neutron capture therapy (BNCT) is an experimental form of radiation therapy for malignant brain tumors and peripheral melanoma. The micro-distribution of the boron compound is critical to determine the radiation effects for both tumors and normal tissue. In the current dose calculation of BNCT, normal brain tissue is considered to have a homogeneous boron concentration. The purpose of this study was to examine the structure-specific boron concentration in normal rat neural tissue. At 10, 30 and 60 min after intravenous injection of 300 mg/kg boronophenylalanine-fructose to 10-week-old CD Fisher rats, neural tissue and blood were collected. Various neural structures were anatomically and histologically identified and specific boron concentrations were analyzed using high-resolution quantitative autoradiography. At 60 min after the injection, only the pituitary gland showed a higher boron concentration than that in blood, with the former being threefold higher. All other neural structures showed lower boron concentrations than that in blood. The present study thus demonstrated an extremely high boron concentration in the pituitary gland following intravenous injection of boronophenylalanine-fructose. In clinical trials of BNCT using an epithermal neutron beam, the radiation dose to the pituitary gland should be carefully evaluated.
Introduction
Boron neutron capture therapy (BNCT) is undergoing clinical trial for the treatment of malignant brain tumors and peripheral melanoma [1] [2] [3] . In this therapy, selective accumulation of boron in the tumor is critical for success. Precise measurement of the boron concentrations in the tumor and venous blood is essential to calculate the dose delivered to the tumor and the normal tissue. Most important dose-limiting factor is normal tissue tolerance. It is thus crucial to determine the exact boron uptake into normal tissue and the radiation dose of normal tissue. In dose calculation in BNCT, normal brain tissues have generally been treated as a single tissue having homogeneous boron distribution and homogeneous radiosensitivity. Reports describing the boron concentration in the normal brain after intravenous infusion of boron compound are scarce [4, 5] . To our knowledge, there has been no study of the boron distribution in normal neural structures. High Resolution Quantitative Autoradiography (HRQAR) is a sensitive method for analyzing boron micro-distribution in tissue [6] [7] [8] [9] . Using HRQAR, boron distributions are observed on histological structure and boron concentrations in specific anatomical structure are calculated. The aim of this study was to investigate the structure-specific distribution of boron in the normal rat brain using HRQAR. We considered that this knowledge would be helpful both for calculating the normal tissue dose and determining the critical normal structure in BNCT.
Materials and methods

Boronophenylalanine-fructose (BPA-f)
Boronophenylalanine (BPA) was purchased from Ryscor Science Inc. (North Raleigh, NC, USA) and converted to BPA-fructose (BPA-f) in our laboratory using previously reported methods [10, 11] . Briefly, BPA and fructose were combined in water, the pH was adjusted to 10.0 with NaOH, the mixture was stirred until all solids dissolved, and the pH was readjusted to 7.4 with HCL.
Animals
Male 10-week-old CD Fisher rats weighing 200 g were purchased from Charles River Laboratories, Inc. (Wilmington, MA, USA). Rats were anesthetized by intraperitoneal injection of ketamine (60 mg/kg) and xylazine (5 mg/kg). Once the rats were sufficiently anesthetized, they were injected with 300 mg/kg of BPA-f through the tail vein using a 27G needle. The rats were sacrificed by pentobarbital overdose (100 mg/kg intraperitoneally) at three different time points (10, 30 , and 60 min after the injection of BPA-f). Blood was collected by cardiac puncture and kept in EDTA-filled test tubes. Blood boron concentrations were measured using prompt gamma ray neutron activation analysis in the Massachusetts Institute of Technology Research Reactor II (MITR-II) [12] . The brain, optic nerve, trigeminal nerve, pituitary gland and cervical spinal cord were removed immediately and put into test tubes. These tubes were stored in a freezer and kept frozen for histological and HRQAR study. Pituitary gland is composed of large adenohypophysis and small neurohypophysis. We anatomically and histologically identified the adenohypophysis, but did not analyze the neurohypophysis in this study. These studies were conducted in accordance with accepted ethical and humane practices and were approved by the Harvard Medical Area Standing Committee on Animals and The Beth Israel Deaconess Medical Center Institutional Animal Care & Use Committee.
High resolution quantitative autoradiography (HRQAR)
HRQAR is a special technique developed in our laboratory. Using this technique we can investigate the subcellular distribution of boron in tumors and the normal brain. The detailed procedures of this technique have been described in other publications [6] . In brief, a quartz glass microslide was coated with a film of Lexan and a thin film of Ixan. Lexan was used as an a and Li-particle detector, and Ixan as a protective layer over the tissue. The two films were laminated together. A boron containing frozen tissue were cut to a thickness of four microns using a cryostat microtome, then immediately placed on a coated and laminated quartz glass microslide. The quartz glass microslides were packed in dry ice and irradiated with thermal neutrons at MITR-II. The tissue on the quartz glass microslide was stained with hematoxylin and eosin (HE). Another glass slide is mounted on the tissue using glycerol/gelatin mountant, and the slides were refrigerated for 5 days at a temperature of 4°C. The quartz glass slides were separated and the outermost Lexan films were etched in KOH solution. The track etchings in the Lexan produced by a and Liparticles and the HE staining of tissue were simultaneously observed under a light microscope. Microscopic images were captured using OpenLab software (Improvision, Coventry, UK) on a Power Macintosh G3 computer connected to a microscope mounted with a CCD camera. The acquired images were analyzed using Trackanalysis software developed in our laboratory on a Power Macintosh G3 computer. The boron concentration in each anatomical and histological structure was measured by comparing with standard samples of known boron concentration. Boron concentrations in the following normal neural tissues were examined: the olfactory bulb, frontal cortex, optic nerve, caudate nucleus, thalamus, hypothalamus, pituitary gland, trigeminal nerve, hippocampus, occipital cortex, cerebellar cortex (molecular layer, granular layer), cerebellar white matter, ventral and dorsal midbrain, pons, medulla, cervical spinal cord, and posterior cerebral artery (PCA). Ten images for each neural structure were analyzed and the mean boron concentrations were calculated. Figure 1 shows typical HRQAR images of the frontal lobe, thalamus and pituitary gland. All samples were taken from the same mouse at 60 min after i.v. administration of 300 mg/kg BPA-f. Figure 2 shows the mean boron concentrations in various nervous system structures. All boron concentrations in neural structures and blood decreased with time. All neural structures showed lower boron concentration than that in blood, except for that in pituitary gland. Boron concentrations in the pituitary gland at 30 and 60 min after intravenous injection of BPA-f were higher than those in blood. The trigeminal nerve showed higher boron concentrations than other neural structures at 10 and 30 min after the injection. At 60 min after the injection, only the pituitary gland showed a higher boron concentration than that in blood, with the former being threefold greater.
Results
Discussion
Analysis of the micro-distribution of boron Several methods are available to investigate the microdistribution of boron in tissue. Traditional neutron-induced autoradiography has high sensitivity for measuring low concentrations of boron in tissue, but its low spatial resolution does not permit investigation of the microdistribution of boron at the cellular or sub-cellular level [13] [14] [15] [16] . Secondary ion mass spectrometry ion microscopy is another of the methods used to measure the microdistribution and concentration of boron [17] [18] [19] . In this method, the distribution of sodium, potassium and calcium can be investigated at the same time. However, it is difficult to correlate the boron micro-distribution with the histological findings using this method, because the cell and nucleus boundaries are not seen directly. Using a resonance ionization microprobe, on the other hand, the boron micro-distribution can be investigated with a spatial resolution at the micrometer level [20] . In this method, the detection limit of boron is relatively high and accurate quantification of boron concentration in tissue was not reported. HRQAR has both high sensitivity and high resolution. HRQAR is the only method that can observe both the boron micro-distribution and the histological findings simultaneously without any superimposing.
Mechanism of BPA uptake into neural tissue
There have been many studies on BPA uptake into tumor cells and tumor tissue. An in vitro tumor study showed that transport of BPA across the cell membrane was dependent both on the time of exposure and the concentration of BPA in the culture medium [21] . A rat brain tumor study has shown that the accumulation of BPA in rapidly growing animal tumors could be due to the metabolic demand for the amino acids needed for protein synthesis [22] . A fluorine-18-labeled L-fluoro-BPA (18F-FBPA) PET study demonstrated that 18F-FBPA was accumulated in the amino acid pool of the tumor tissue by a retention mechanism via the amino acid anabolic pathway rather than by incorporation into proteins [23] . On the other hand, the uptake mechanisms of BPA into normal neural tissue are not completely understood. Chuang examined the boron concentration in normal neural tissues of rats after intravenous injection of BPA-f [24] . The boron concentrations in the cerebellum and brain stem were slightly higher and that in the cranial nerve was 1.5 times higher than that in the cerebrum. The boron concentration was measured with inductively coupled plasma atomic emission spectroscopy (ICP-AES), so more detailed anatomical structure-specific data were not available.
Regional cerebral blood flow
Because blood flow delivers intravenously injected BPA-f into neural structures, we reviewed the correlation between regional cerebral blood flow (rCBF) and boron concentration in neural tissue. Various authors have reported on rCBF in rats [25] [26] [27] [28] [29] [30] [31] . All these rCBF data were measured using autoradiography with 14C-iodoantipyrine. This method is well established and is used as a standard reference when examining the efficacy of new methods [32] [33] [34] . Generally, rCBF values are closely coupled to the respective metabolic rates [26, 28] . And rCBF depends on age, anesthetic condition and species of animals [27, 30, 31] . Generally, the cerebral cortex, basal ganglia (caudate, putamen, thalamus), cerebellar cortex, midbrain and pons show high mean rCBF values of between 1.0 and 1.5 ml/g/ min; the cerebral white matter, corpus callosum, optic nerve, pituitary gland, cerebellar white matter and spinal cord show low mean rCBF values of about 0.5 ml/g/min; and the hypothalamus, hippocampus and medulla show intermediate mean rCBF values of between 0.5 and 1.0 ml/g/min. The cerebral cortex, caudate, thalamus, hypothalamus, hippocampus and cerebellar cortex showed high boron concentrations at 10 min after i.v. injection. Most of these high boron concentrations can be attributed to the high rCBF levels. However, the extremely high boron concentrations in the pituitary gland and trigeminal nerve cannot be explained by rCBF.
Phenylalanine influx into neural tissue
Hawkins et al. examined radioactive phenylalanine influx into various cerebral structures in rats after intravenous injection using quantitative autoradiography [35] . They demonstrated that the phenylalanine influx varied considerably among structures, with the highest rate of influx occurring in the inferior colliculus in the dorsal midbrain and the lowest in the globus pallidus. Moguilevsky et al. examined phenylalanine incorporation into neural tissue after intravenous injection [36] . The anterior pituitary gland showed high phenylalanine incorporation, more than double those of the hypothalamus and cerebral cortex. They concluded that the anterior pituitary gland has a higher protein synthetic activity than the hypothalamus or the cortex. Movement of large neutral amino acids across the blood brain barrier (BBB) is mediated by a common high affinity, low capacity L amino acid transport system. A large excess of one of the large neutral amino acids will saturate this carrier system, thereby excluding other amino acids in the group from entry into the brain [37] . Organs outside the BBB, such as the pituitary gland, have high capacity amino acid transport systems, and competitive effects are not seen [38, 39] . Generally, metabolic demand, amino acid supply, glucose utilization and blood flow are well correlated [26, 28] . In the present study, the cerebral cortex, cerebellar cortex, thalamus, midbrain and pons showed high rCBF and high phenylalanine influx. The dorsal midbrain showed particularly high values for both these parameters. The cerebral white matter, cerebellar white matter and hypothalamus showed low rCBF and low phenylalanine influx. The pituitary gland had a low rCBF value, but the finding of a high boron concentration in the pituitary gland was reasonable because the pituitary gland has a high protein synthetic activity and high capacity amino acid transport system.
Boron accumulation in the dopaminergic neurons Dopamine synthesis originates from the amino acid precursors phenylalanine and tyrosine. Setiawan et al. investigated the accumulation of BPA in the catecholamine-containing neurons, because BPA may be a precursor for the catecholamine neurotransmitters [40] . However, it was not possible to measure boron localization in the mouse brain using the neutron capture autoradiography employed in their study. Their immunohistochemical study showed a transient decrease of tyrosine hydroxylase activity in the dopaminergic fibers and cell bodies 4 h after BNCT with BPA. Although this effect recovered by 48 h, it should be dependent on the dose of injected BPA and neutron fluence. These results demonstrated that BPA accumulates in the dopaminergic neurons and transiently affects catecholamine-synthesizing pathways.
We did not investigate dopamine neuron-specific BPA uptake. The central nervous dopaminergic system includes the olfactory, tuberohypophysial, incentohypothalamic, and medullary neurons, and the ventral tegmental, substantia nigra, caudate-putamen and limbic systems [41] . Previous studies have demonstrated the accumulation of dopamine and L-dopa in the pituitary gland [42] [43] [44] . In the present study, we observed an extremely high BPA uptake only in the pituitary gland. This high boron concentration in the pituitary gland might be partially attributed to BPA uptake into the pituitary gland as a precursor of dopamine. However, we did not observe a high boron concentration in other neural structures containing dopaminergic neurons. The purpose of the present study was to quantify the boron localization in gross anatomical structures. The boron uptake to specific types of neurons should be investigated in a future study. The combination of HRQAR and immunohistochemical staining might provide valuable findings. The current treatment planning system, however, cannot avoid the irradiation of particular types of neurons, although it can avoid irradiation to critical structures by means of fine treatment planning.
Normal tissue tolerance dose
Because BNCT is given as high dose radiation therapy with or without some fractionations, the normal tissue tolerance in radiosurgery becomes the reference value. Recent developments and clinical experiences of radiosurgery have revealed the normal tissue tolerance dose of high dose radiation therapy. The optic nerve, brain stem and hypothalamo-pituitary axis are critical normal structures in radiosurgery. The reported tolerance doses of the optic nerve to radiosurgery range from 8 to 10 Gy [45, 46] . Other cranial nerves are relatively resistant to single large doses of radiation, except for the chochlear nerve [46] [47] [48] . The brain stem is radiosensitive, and brain stem doses greater than 16 Gy are associated with a high risk of cranial neuropathy [49] . The hypothalamo-pituitary axis is also radiosensitive, and the effect of irradiation of this axis is time-and dose-dependent [50] . The pituitary complications occurred at doses substantially less than those commonly used for the tumor treatment and the minimum reported total dose required to induce pituitary dysfunction was 30 Gy with 20 fractionations [51, 52] . The clinical manifestations of hypopituitarism depend on which hormones are lost and the extent of the hormone deficiency [53] . Provocative tests may be required to assess pituitary reserve. These endocrine consequences of radiation are believed to reflect hypothalamic damage rather than anterior pituitary damage [50, 51] . In BNCT, the boron concentration in tissue is one of the factors used to determine the radiation dose. Based on our present findings, the pituitary gland and trigeminal nerve should be treated as critical structures that have high boron concentrations. There have been no reported cases of pituitary dysfunction or cranial nerve palsy directly as a consequence of BNCT for intracranial tumor. Epithermal neutrons are able to deliver a larger amount of neutron fluence into the deep intracranial structures than thermal neutrons. The BNCT clinician should be aware of the possibility of pituitary dysfunction and cranial nerve palsy after BNCT. To avoid these complications, precise knowledge of the boron concentration in normal neural tissue and fine treatment planning that includes consideration of the pituitary gland and cranial nerve are required. For numerous reasons, the present results in rats cannot be directly translated to humans. A boron distribution study using large primates or other mammals would be helpful for estimating the boron distribution in human neural tissue.
The compound biological effectiveness (CBE) factor has been used to describe the effects of the dose component due to B(n,a)Li reaction [54, 55] . The CBE factor is a combination of the relative biological effectiveness of a particles and the biodistribution of the boron compound at the cellular and subcellular levels. The CBE factor for normal brain was derived in the rat spinal cord [56] . At 60 min after the intravenous injection of BPA, the boron concentration in the spinal cord was almost the same or higher than the boron concentration in most normal neural tissues, except for the pituitary gland. Thus the CBE factor derived from the rat spinal cord is reasonable as the representative CBE factor for normal neural tissue, except in the case of the pituitary gland. More detailed, structure-specific measurements of CBE should be made in a future study.
